The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program Home
Abstract Details
|
Activity Number:
|
555
|
|
Type:
|
Topic Contributed
|
|
Date/Time:
|
Wednesday, August 1, 2012 : 2:00 PM to 3:50 PM
|
|
Sponsor:
|
Section on Bayesian Statistical Science
|
| Abstract - #306368 |
|
Title:
|
Bayesian Approach in Phase III Outcome Prediction Aiming Early Phases Decisionmaking
|
|
Author(s):
|
Yuanjun Shi and Bronwyn Loong and Huyuan Yang*+
|
|
Companies:
|
Millennium Pharmaceuticals, Inc. and Harvard University and Millennium Pharmaceuticals, Inc.
|
|
Address:
|
35 landsdowne st, cambridge, MA, , use
|
|
Keywords:
|
Phase I/II ;
Bayesian imputation
|
|
Abstract:
|
The failure rate and cost in clinical development in oncology drugs are very high, this is mainly caused by predictions based on small sample size and noncomparative phase I/II trials are not reliable to support decision making and design of phase III clinical trials. Modeling clinical trials in a Bayesian framework enhances both statistical and medical effectiveness in clinical trial operations and decision making, by drawing information from the collection of prior studies. Phase III data will be imputed based on Phase I/II data towards clinical response predictions. The proposed modeling can access more information from Phase I/II studies and improve the efficiency in decision making
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2012 program
|
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.